sever
pneumonia
remain
major
reason
admiss
intens
care
unit
icu
mainli
relat
streptococcu
pneumonia
sp
atyp
pneumonia
ap
relat
instanc
chlamydophila
pneumonia
cp
mycoplasma
pneumonia
mp
account
document
pneumonia
patient
admit
icu
although
ap
rare
sever
patient
communityacquir
ap
requir
icu
admiss
sever
retrospect
studi
report
icu
admiss
patient
ap
one
studi
even
patient
ap
older
year
admit
icu
among
icuadmit
patient
ap
requir
mechan
ventil
acut
respiratori
distress
syndrom
ard
patient
previou
studi
mortal
rate
low
around
although
recent
retrospect
studi
found
mortal
popul
high
rate
coinfect
cardiac
complic
previou
nonicu
studi
compar
bacteri
pneumonia
ap
associ
younger
age
fewer
comorbid
lower
risk
sever
respiratori
failur
better
outcom
patient
admit
icu
studi
remain
rare
main
object
studi
describ
ap
patient
admit
icu
secondari
object
compar
diagnost
strategi
outcom
mycoplasma
pneumoniaerel
pneumonia
mp
streptococcu
pneumoniaerel
pneumonia
sp
admit
icu
retrospect
chart
review
adult
admit
icu
franc
diagnosi
ap
period
addit
file
figur
inclus
criteria
pneumonia
defin
sepsi
new
pulmonari
infiltr
chest
radiograph
either
posit
specif
polymeras
chain
reaction
pcr
test
mp
cp
respiratori
specimen
noninvas
sampl
bronchoalveolar
lavag
blood
serolog
test
suggest
acut
mp
cp
infect
elev
specif
igm
fourfold
increas
igg
level
two
time
point
elev
antimp
igg
combin
presenc
cold
agglutinin
studi
approv
local
ethic
committe
de
de
langu
ce
srlf
clinic
laboratori
data
icu
admiss
collect
well
organ
failur
icu
stay
sap
ii
score
use
assess
sever
icu
admiss
also
collect
extrapulmonari
symptom
arthriti
defin
new
inflamm
one
joint
myocard
cardiac
dysfunct
troponin
elev
cutan
involv
onset
skin
rash
bacteri
andor
viral
coinfect
diagnosi
record
patient
mpap
compar
group
consecut
patient
proven
spp
admit
one
studi
icu
saint
loui
hospit
pari
period
spp
diagnos
base
sepsi
new
pulmonari
infiltr
identif
sp
least
one
microbiolog
specimen
blood
cultur
respiratori
specimen
urinari
antigen
altern
diagnosi
categor
variabl
describ
n
quantit
variabl
median
percentil
first
describ
featur
patient
ap
icu
admiss
conduct
univari
analys
nonparametr
test
compar
group
mpap
spp
final
multipl
correspond
analysi
mca
perform
identifi
dimens
associ
paramet
icu
admiss
hiv
symptom
durat
shock
confus
diarrhea
physic
chest
find
chest
radiograph
abnorm
bilirubin
level
hemolyt
anemia
caus
organ
use
factomin
librari
r
softwar
platform
mca
extens
simpl
correspond
analysi
design
analyz
relat
among
categor
variabl
aim
redefin
princip
dimens
axe
space
way
captur
highest
possibl
percentag
inertia
liken
explain
varianc
test
twotail
p
valu
consid
signific
statist
analys
carri
use
r
statist
platform
http
wwwrprojectorg
includ
patient
men
women
median
age
year
addit
file
tabl
acut
respiratori
failur
main
reason
icu
admiss
n
reason
cardiovascular
failur
n
neurolog
disord
n
miscellan
reason
n
ap
common
fall
winter
fig
furthermor
ap
becam
common
time
suggest
improv
diagnosi
introduct
pcr
test
tabl
addit
file
tabl
report
main
featur
patient
ap
common
comorbid
chronic
respiratori
diseas
present
patient
includ
patient
chronic
obstruct
lung
diseas
patient
asthma
patient
interstiti
lung
diseas
patient
patient
longterm
oxygen
therapi
icu
admiss
immunosuppress
note
patient
includ
hematolog
malign
lymphoma
n
solid
cancer
hiv
infect
delay
respiratori
symptom
onset
icu
admiss
day
fever
defin
bodi
temperatur
present
patient
icu
admiss
patient
tachypn
respiratori
rate
min
sever
respiratori
symptom
physic
chest
examin
includ
crackl
n
rhonchi
n
wheez
n
sign
consolid
n
squeak
report
extrapulmonari
symptom
concern
patient
includ
arthriti
n
myocard
n
skin
rash
n
almost
onethird
patient
n
neurolog
symptom
icu
admiss
mostli
alter
level
conscious
relat
sever
sepsi
hypoxemia
confus
main
symptom
patient
meningoenceph
diagnos
patient
cold
agglutinin
assess
case
hemolyt
anemia
posit
mp
patient
cytolysi
occur
patient
rhabdomyolysi
present
patient
icu
admiss
patient
shock
sofa
score
sap
ii
common
find
chest
radiographi
alveolar
opac
n
interstiti
opac
n
quadrant
pleural
effus
rare
n
caus
organ
mp
patient
cp
patient
identifi
serolog
test
posit
igm
elev
igg
patient
posit
pcr
respiratori
sampl
patient
bronchoalveolar
lavag
nasopharyng
aspir
tracheal
aspir
nasal
swab
diagnost
method
patient
none
collect
variabl
differ
patient
diagnos
pcr
serolog
addit
file
tabl
coinfect
found
patient
relat
virus
n
influenza
rhinoviru
respiratori
syncyti
viru
coronaviru
bacteria
n
haemophilu
influenza
proteu
mirabili
staphylococcu
aureu
serratia
marcescen
pneumocysti
jirovecii
n
none
mp
patient
coinfect
cp
sp
mechan
ventil
requir
patient
last
day
patient
meet
criteria
ard
requir
extracorpor
membran
oxygen
vasoact
agent
requir
patient
renal
replac
therapi
start
patient
firstlin
antibiot
activ
mp
cp
patient
time
icu
admiss
antibiot
initi
day
combin
therapi
use
patient
consist
thirdgener
cephalosporin
macrolid
patient
quinolon
patient
anoth
betalactam
macrolid
patient
anoth
betalactam
quinolon
patient
anoth
antibiot
macrolid
patient
antibiot
adapt
accord
microbiolog
result
macrolid
n
quinolon
n
cyclin
n
eleven
patient
die
icu
icu
stay
length
day
persist
hypoxemia
present
icu
discharg
patient
univari
analysi
factor
associ
mortal
age
year
p
sign
respiratori
distress
p
interstiti
opac
chest
radiograph
p
mp
patient
receiv
adequ
antibiot
icu
admiss
among
patient
die
tabl
report
univari
analysi
compar
patient
mpap
spp
factor
significantli
associ
spp
hiv
infect
vs
p
neurolog
symptom
vs
p
gastrointestin
symptom
vs
p
factor
significantli
associ
mp
hemolyt
anemia
cold
agglutinin
vs
p
also
patient
spp
coinfect
influenza
n
haemophilu
influenza
n
streptococcu
constellatu
n
spp
associ
shorter
length
respiratori
symptom
icu
admiss
day
vs
day
p
icu
admiss
sap
ii
score
higher
spp
vs
p
shock
frequent
vs
p
creatinin
level
higher
vs
p
lactat
level
high
mmoll
vs
mmoll
p
sign
consolid
decreas
breath
sound
common
spp
mpap
vs
vs
respect
mpap
involv
quadrant
chest
xray
vs
p
less
frequent
pleural
space
vs
p
bilirubin
level
higher
patient
spp
vs
p
mpap
associ
use
mechan
ventil
vs
p
icu
length
stay
lo
seem
prolong
case
mpap
regardless
icu
outcom
median
lo
vs
day
vs
day
respect
patient
die
icu
patient
discharg
aliv
howev
mortal
lower
mpap
group
vs
p
figur
show
mca
result
clinic
radiolog
characterist
admiss
sever
characterist
discrimin
mp
cp
mp
often
associ
hemolyt
anemia
abdomin
manifest
extens
chest
radiograph
abnorm
spp
associ
shock
confus
focal
crackl
focal
consolid
multicent
studi
largest
one
analyz
ap
patient
admit
icu
extrapulmonari
symptom
seen
onethird
patient
correspond
data
previou
studi
patient
admit
icu
howev
ap
nonicu
patient
describ
mild
wherea
substanti
proport
patient
sever
acut
pneumonia
shock
icu
admiss
patient
mechan
ventil
requir
patient
includ
patient
ard
previou
studi
patient
mpap
younger
fewer
comorbid
lower
respiratori
diseas
sever
better
outcom
studi
icu
patient
age
similar
patient
mpap
spp
previou
studi
also
compar
clinic
radiolog
featur
accord
caus
organ
pneumonia
japanes
cohort
among
patient
pneumonia
audibl
crackl
often
heard
late
inspir
patient
ap
throughout
inspir
patient
bacteria
studi
patient
mpap
specif
clinic
find
except
sign
consolid
associ
spp
radiolog
find
compar
spp
mpap
often
respons
groundglass
opacif
centrilobular
nodul
bronchial
wall
thicken
diffus
radiolog
abnorm
studi
extens
interstiti
pneumonia
common
mpap
spp
japanes
respiratori
societi
publish
guidelin
identifi
mpap
establish
score
system
base
six
paramet
age
year
minor
comorbid
stubborn
cough
abnorm
chest
auscult
absenc
sputum
etiolog
agent
identifi
rapid
diagnost
test
peripher
white
blood
cell
count
score
indic
high
probabl
mpap
sensit
specif
anoth
score
system
perform
well
separ
patient
pneumonia
three
group
pyogen
bacteria
mp
cp
viru
unknown
agent
nevertheless
neither
score
system
assess
icu
patient
studi
mca
provid
insight
differ
mpap
spp
hemolyt
anemia
diffus
chest
radiograph
abnorm
interstiti
opac
associ
mpap
contrari
hiv
infect
shock
neurolog
symptom
gastrointestin
symptom
sign
consolid
shorter
symptom
durat
higher
bilirubin
level
radiolog
alveolar
opac
strongli
link
spp
compar
patient
spp
mpap
often
requir
mechan
ventil
spent
time
icu
yet
lower
risk
death
lower
mortal
may
ascrib
smaller
number
mpap
patient
extrapulmonari
organ
failur
shock
neurolog
manifest
acut
renal
failur
lower
sap
ii
sever
score
mpap
group
vs
p
interestingli
intracellular
pathogen
underdiagnos
like
virus
undercov
despit
avail
therapeut
agent
find
line
menendez
et
al
report
lack
antibiot
complianc
patient
cap
descript
data
may
use
help
clinician
discrimin
sprelat
pneumonia
mprelat
pneumonia
even
doubl
antibiotherapi
activ
atyp
pathogen
recommend
sever
patient
studi
sever
limit
first
studi
design
retrospect
patient
includ
within
period
icu
manag
may
chang
period
icu
admiss
criteria
could
differ
accord
center
year
admiss
atyp
pneumonia
remain
rare
main
object
studi
describ
ap
sever
patient
howev
studi
assess
mostli
clinic
radiolog
characterist
admiss
would
unlik
chang
center
secondarili
spp
patient
includ
one
singl
center
wherea
ap
patient
includ
sever
center
main
object
studi
describ
patient
icu
admiss
although
admiss
rule
would
differ
center
clinic
present
would
affect
thirdli
patient
proven
ap
base
posit
microbiolog
sampl
includ
half
patient
mpap
diagnosi
base
serolog
test
recent
pcr
use
diagnos
mycoplasma
pneumonia
infect
posit
igm
antimp
consid
gold
standard
pcr
sensit
equal
although
patient
serolog
test
fourfold
increas
igg
level
two
time
point
believ
includ
proven
mpap
patient
although
differ
diagnost
test
use
within
studi
period
among
center
test
enough
sensit
specif
includ
real
mpap
pneumonia
fourth
includ
patient
legionella
pneumophila
pneumonia
frequent
atyp
pneumonia
although
legionella
pneumophila
pneumonia
associ
higher
risk
icu
admiss
compar
mpap
cpap
goal
focu
ap
usual
nonsever
occasion
lead
icu
admiss
moreov
sever
studi
analyz
legionella
pneumophila
pneumonia
similarli
includ
rare
etiolog
pneumonia
q
fever
although
consid
less
sever
pneumonia
atyp
pneumonia
requir
icu
admiss
remain
associ
mortal
icu
admiss
sever
clinic
radiolog
featur
could
differ
mpap
spp
may
help
physician
prospect
studi
need
valid
clinic
model
ap
icu
patient
